UBC researchers have matched peptides with antibiotics so they can work together to combat hard-to-treat infections that don’t respond well to drugs on their own. The study builds on previous research that showed that the peptides are key to making harmful bacteria more responsive to drugs.
The study aimed to find new treatments for infections caused by antimicrobial-resistant bacteria including Escherichia coli and the so-called ESKAPE pathogens, a group named from the first-letter of six bacteria species: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter. These infections collectively account for more than 60% of all hospital infections, manifesting as abscesses in the skin or infections in internal tissues like the lungs or urinary tract.
Most antibiotics are designed to work on bacteria that are swimming freely in the body. However, in the majority of infections, bacteria grow together on body surfaces in massive communities known as biofilms, shielded by a protective structure. Together, biofilm bacteria adapt to stress by learning to resist the immune system and chemicals, making them extremely resistant to antibiotics and difficult to treat.
The peptides help several antibiotics to work by removing the bacteria’s ability to respond to stress and form these resistant communities. To find the best combination of peptide and drug, the researchers tested different options in a laboratory setting. Once they identified possible mixtures, they tested them in mice with abscesses on their skin. In total, they found seven combinations that worked better than antibiotics on their own.
When the peptides worked in combination with the drugs, the researchers observed a reduction in the size of the abscess in mice and the number of bacteria in the infection area. The combinations offered up to 100-fold improvement.
The results are particularly important for patients with cystic fibrosis who often deal with dense, chronic infections in the lungs. The disease causes mucus to build up around tissues, creating an ideal environment for bacteria to form biofilms and thrive.
Researchers are hoping to commercialize this treatment and have licensed the peptides to ABT Innovations, a UBC spinoff company owned by Dr Bob Hancock.
The research was funded by Cystic Fibrosis Canada, a Canadian Institutes of Health Research Foundation grant, the Canada Research Chair program, and the Alexander von Humboldt Foundation. The study was published in PLOS Pathogens.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org